Impact of late‐onset cytomegalovirus infection in the development of cardiac allograft vasculopathy in heart transplant recipients-Reference-Cited by-同舟云学术

Impact of late‐onset cytomegalovirus infection in the development of cardiac allograft vasculopathy in heart transplant recipients

Published:2020-10-13 Issue:2 Volume:23 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl. Infect. Dis.

Author:

Ponz de Antonio Inés¹,Rodríguez Chaverri Adriana¹,García Reyne Ana²,Carrasco Antón Nerea²,Lora Pablos David³,López Medrano Francisco²^ORCID,Dios Santiago⁴,Jurado Alfonso⁵,Folgueira María D.⁶,García‐Cosio Carmena María D.¹,Arribas Ynsaurriaga Fernando¹⁷⁸,Aguado José M.²,Lumbreras Carlos²,Delgado Jiménez Juan F.¹⁷⁸^ORCID

Affiliation:

1. Cardiology Department University Hospital 12 de OctubreInstituto de Investigación Sanitaria Hospital 12 de Octubre (i+12) Madrid Spain

2. Infectious Disease Unit University Hospital 12 de OctubreInstituto de Investigación Sanitaria Hospital 12 de Octubre (i+12) Madrid Spain

3. Centro de Investigacion Biomedica Epidemiologia y Salud Publica (CIBERESP) Madrid Spain

4. Cardiology Department Hospital Sanitas La Zarzuela Madrid Spain

5. Cardiology Department University Hospital La Paz Madrid Spain

6. Microbiology Department University Hospital 12 de OctubreInstituto de Investigación Sanitaria Hospital 12 de Octubre (i+12) Madrid Spain

7. Centro de Investigación Biomédica En Red Cardiovascular (CIBERCV) Madrid Spain

8. Facultad de Medicina Universidad Complutense de Madrid Madrid Spain

Funder

European Regional Development Fund

Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13479

Reference27 articles.

1. Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients

2. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials

3. Infection in solid organ transplantation

4. Impact of Cytomegalovirus in Organ Transplant Recipients in the Era of Antiviral Prophylaxis

5. Pre-emptive treatment with oral valganciclovir in management of CMV infection after cardiac transplantation

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicenter study of universal prophylaxis versus pre‐emptive therapy for patients at intermediate risk (R+) for CMV following heart transplantation;Clinical Transplantation;2023-07